lung cancer | |||||
新闻 | |||||
Discovery of EGFR mutations dramatically changed lung cancer treatment May 2024 marks the 20th anniversary of the publication of papers on the role of the EGFR mutation in lung cancer. This is a seminal event that ...
| |||||
Pfizer Study Shows Lorbrena Reduces Chances of Lung Cancer Getting Worse By Denny Jacob Pfizer said a majority of patients in a study of its lung cancer treatment Lorbrena remained alive after five years without the ...
| |||||
Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression ... Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study.
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment